Skip to main content
Equibles

Legal & General Group Plc

Position in CGON — CG Oncology, Inc.

CIK 764068 London, X0
Back to CGON Full portfolio

Position in CGON

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,846,404
+$274,024 QoQ
Shares Held
40,062
+5.4% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGON Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. CGON ranks #66 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in CGON

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,846,404 40,062
2026-03-31 $2,572,380 38,008
2025-12-31 $1,874,502 45,147
2025-09-30 $1,741,626 43,238
2025-06-30 $1,153,204 44,354
2025-03-31 $967,525 39,507
2024-12-31 $839,233 29,262
2024-09-30 $920,497 24,397
2024-06-30 $604,091 19,135
2024-03-31 $94,911 2,162